IBS Symptoms: Signs, Triggers and What Helps

IBS symptoms are belly pain or cramps tied to bowel movements, plus changes in how often you go or what your stool looks like. About 9% of adults worldwide have irritable bowel syndrome under the older Rome III criteria, a 2020 review of 53 studies found.

IBS doesn’t damage your gut.

But it can make daily life hard, and some of its symptoms overlap with conditions that need a doctor.

This guide covers the main symptoms, the types, common triggers and which self-care options hold up in trials. For everyday gut care, see the gut health habits that work.

Key takeaways
  • About 9.2% of adults worldwide have IBS under the older Rome III criteria, and it’s more common in women (12.0%) than men (8.6%).
  • Under today’s stricter Rome IV definition, 4.1% of 54,127 internet survey adults in a 33-country study had IBS.
  • In a 2025 review of 28 diet trials (2,338 people), a low FODMAP diet had the most evidence of any diet for overall IBS symptoms.
  • Brain-gut therapies such as CBT helped overall symptoms more than a waiting list across 67 trials (7,441 people) in a 2025 review, but the authors rated certainty low or very low.
  • 4 warning signs call for an urgent appointment, including bleeding from your bottom and weight loss you can’t explain.

What are the main IBS symptoms?

The main IBS symptoms are belly pain linked to bowel movements, bloating, and diarrhea, constipation or both. Many people also feel they haven’t fully emptied their bowels. Symptoms often come and go over months or years.

Here’s what the four main ones usually feel like:

  • Stomach pain or cramps: usually worse after eating and better after a bowel movement
  • Bloating: your belly may feel uncomfortably full and swollen
  • Diarrhea: watery stool, sometimes with a sudden need to go
  • Constipation: straining, and feeling you can’t empty your bowels fully

Other irritable bowel syndrome symptoms can include gas, mucus in your stool, tiredness, nausea, back pain and needing to pee often or urgently.

If bloating is your biggest problem, these graded remedies for bloating go into more detail.

How common is IBS? It depends on how strictly IBS is defined.

A 2020 review of 53 studies pooled surveys of 395,385 people in 38 countries. Under the older Rome III criteria, 9.2% had IBS. It was more common in women (12.0%) than in men (8.6%).

Today, doctors and researchers use a stricter set of criteria called Rome IV. A Rome Foundation survey of 73,076 adults covered 33 countries. Online, 4.1% met the Rome IV criteria for IBS, vs 10.1% under the older Rome III criteria.

In household interviews, the figures were 1.5% and 3.5%.

You may also see leaky gut blamed for these symptoms. Here’s what the research says about leaky gut.

What are the types of IBS, and what do IBS stools look like?

Doctors sort IBS into types by the kind of stool you have on days when your bowel movements aren’t normal. The Rome IV criteria, the definitions doctors use, sort the three main types this way:

TypeWhat the stools are like
IBS-C (constipation)More than a quarter are hard or lumpy, and less than a quarter are loose or watery
IBS-D (diarrhea)More than a quarter are loose or watery, and less than a quarter are hard or lumpy
IBS-M (mixed)More than a quarter are hard or lumpy, and more than a quarter are loose or watery

Still, only a doctor can confirm IBS and its type, so don’t use this table to diagnose yourself.

The US gut doctors’ guideline suggests a “positive” diagnosis. That means a doctor diagnoses IBS from your symptom pattern, plus a few targeted tests, rather than ruling out every other condition first.

What triggers IBS flare-ups, and what causes IBS?

IBS symptoms often flare after certain foods or drinks, during stress, or for no clear reason at all. In a Swedish study of 197 people with IBS, these foods were blamed most often:

  • Fried foods (52%)
  • Dairy products (49%)
  • Beans (36%)
  • Apples (28%) and flour (24%)

These are self-reports, not triggers tested in trials, so your own may differ. Stress matters too. In a 2025 review of 96 studies, people reporting stress had about 2.5 times the odds of having IBS.

So what are the worst foods for IBS? Many people react to FODMAPs.

These are short-chain carbs (fermentable sugars and fibers) that the small intestine absorbs poorly. Gut bacteria ferment them, which can cause gas, pain and bloating. A dietitian can help you find out which ones affect you.

The exact cause of IBS isn’t known. Research points to several factors:

  • Problems with how the brain and gut work together, which is why doctors now call IBS a disorder of gut and brain interaction
  • A gut infection: in a 2017 review of 45 studies, about 1 in 10 people had IBS a year after infectious gastroenteritis
  • Anxiety and depression, which were each linked to about 2 to 3 times the odds of IBS in the 2025 review
  • Food intolerances or sensitivities, as in the Swedish study above

Also, some people notice their gut is worse at certain times of day. If yours hurts most after waking, see what can cause stomach pain first thing in the morning.

What helps IBS symptoms?

A low FODMAP diet has the strongest evidence for IBS symptoms. Brain-gut therapies, peppermint oil capsules, fiber, exercise and probiotics have weaker support.

However, most of these trials mixed all types of IBS together. Use the finder to see the options for your type.

IBS self-care options by type
Option, the IBS types it covers, and the main caveatGrade
A low FODMAP diet, with a dietitian
Tested or advised for: IBS-C, IBS-D, mixed (IBS-M)
Eased overall symptoms, pain and bloating across 24 trials. It didn’t clearly change bowel habit, so it may not fix constipation or diarrhea itself.
Strong
Brain-gut therapies (CBT, gut-directed hypnotherapy)
Tested or advised for: IBS-C, IBS-D, mixed (IBS-M)
Helped overall symptoms more than a waiting list in 67 trials, but no trial was at low risk of bias and the authors rated the evidence low or very low. Ask your doctor about a referral.
Low
Peppermint oil capsules
Tested or advised for: IBS-C, IBS-D, mixed (IBS-M)
Helped overall symptoms and pain in 10 trials, but evidence quality was very low and side effects were more common.
Low
Soluble fiber
Tested or advised for: IBS-C, IBS-D, mixed (IBS-M)
Small benefits, with low to very low certainty in reviews of trials.
Low
Regular physical activity
Tested or advised for: IBS-C, IBS-D, mixed (IBS-M)
May help symptoms, but the evidence is very uncertain.
Low
Probiotics
Tested or advised for: IBS-C, IBS-D, mixed (IBS-M)
A few strains showed some benefit, but most results were low or very low certainty.
Low
Ask about tests for celiac disease and IBD
Tested or advised for: IBS-D, mixed (IBS-M)
In a 2017 review of 36 studies, people with IBS symptoms were about 4.5 times more likely than others to have biopsy-confirmed celiac disease. The US gut doctors’ guideline suggests these tests when diarrhea is part of the picture. This is a doctor’s check, not self-care.
Reference source

Most IBS trials mixed all types together, so most grades are the same for every type. The finder sorts what the research says. It doesn’t diagnose your type of IBS or tell you what to take.

1. A low FODMAP diet, with a dietitian

A low FODMAP diet cuts back on fermentable carbs for a short time, then adds them back to find your triggers.

In the 2025 review of 28 diet trials, low FODMAP was tested in 24 of them.

Compared with a usual diet, it cut the chance of overall symptoms not improving by about half. It also helped belly pain and bloating.

However, it didn’t clearly change bowel habit. The US gut doctors’ guideline recommends a limited trial of this diet, not a lifelong one.

Verdict: Strong

The best-tested diet for IBS. It’s restrictive, so do it with a dietitian, not on your own.

2. Brain-gut therapies (CBT and gut-directed hypnotherapy)

Doctors now class IBS as a disorder of how the gut and brain work together. Therapies that work on that link can ease gut symptoms, even though IBS isn’t “all in your head.”

A 2025 review of 67 trials included 7,441 people. Overall, several talking and behavioral therapies helped IBS symptoms more than being on a waiting list.

These included cognitive behavioral therapy (CBT), self-management programs and gut-directed hypnotherapy. Likewise, an earlier review of 41 trials found the same pattern.

But no trial in the 2025 review was at low risk of bias, and the authors rated certainty low or very low.

Verdict: Low

In short, two large reviews found these therapies helped more than a waiting list, but the trials were weak and the authors rated the evidence low or very low. Still, you can ask your doctor about a referral.

3. Peppermint oil capsules

Enteric-coated peppermint oil capsules are made to open in the gut rather than the stomach.

A review of 10 trials with 1,030 people found they helped overall IBS symptoms and belly pain more than a placebo.

Still, the authors rated the evidence very low quality, and side effects were more common.

Also, note that peppermint tea wasn’t tested in these trials. Here’s peppermint tea vs peppermint oil, if you’re weighing the two.

Verdict: Low

The trials favored the capsules over a placebo, but the authors rated that evidence very low quality. Check with your doctor or pharmacist first.

4. Soluble fiber

Soluble fiber dissolves in water and forms a gel in the gut. It’s different from the rough, insoluble fiber in bran.

An umbrella review of 175 trials found soluble fiber improved IBS symptoms. But the effects were mostly small, with low to very low certainty. To learn more, see why fiber matters for your gut.

Verdict: Low

A small benefit at best, from uncertain evidence.

5. Exercise and yoga

Staying active is good for your overall health, and it may help your gut too.

A Cochrane review of 11 trials with 622 people found physical activity may improve IBS symptoms. But the evidence was very uncertain, and no trial was at low risk of bias. Yoga didn’t clearly beat walking in the two trials that compared them.

Verdict: Low

Worth doing for your health, but not proven for IBS symptoms.

6. Probiotics

Probiotics are live microbes in supplements and some foods.

A review of 82 trials with 10,332 people found only 24 were at low risk of bias. A few strains showed some benefit for overall symptoms or pain, but most results were low or very low certainty. Side effects weren’t more common than with a placebo.

So, here’s what probiotics can and can’t do in more detail.

Verdict: Low

No probiotic is a reliable fix for IBS so far.

When to see a doctor

UK health service guidance advises seeing a doctor if you think you might have IBS and your symptoms have lasted more than 4 weeks.

A doctor can check for IBS and rule out other conditions.

These signs aren’t typical of IBS. Get them checked quickly:

SignWhat to doBasis
Weight loss you can’t explainAsk for an urgent appointmentUK care guidance
Bleeding from your bottom, or bloody diarrheaAsk for an urgent appointmentUK care guidance
A hard lump or swelling in your bellyAsk for an urgent appointmentUK care guidance
Shortness of breath, a pounding heartbeat and paler skin than usualAsk for an urgent appointmentUK care guidance
Diarrhea as a main symptomAsk your doctor about tests for celiac disease and inflammatory bowel diseaseACG guideline
Don’t self-diagnose

IBS shares symptoms with other conditions, such as celiac disease and inflammatory bowel disease. Celiac disease was about 4.5 times more common in people with IBS symptoms in the 2017 review. That’s why doctors test for it, and why the warning signs above need a doctor quickly.

FAQ

What do IBS stools look like?

It depends on your type. In IBS-C, more than a quarter of stools are hard or lumpy. In IBS-D, more than a quarter are loose or watery, and mixed IBS has both. Mucus in the stool is common, but blood is not, so see a doctor if you notice it.

What triggers an IBS flare-up?

In a Swedish study of 197 people with IBS, fried foods, dairy and beans were the foods blamed most often. Stress is linked to IBS too. Flare-ups can also happen for no clear reason, and triggers vary from person to person.

How can I reduce IBS symptoms?

A low FODMAP diet, done with a dietitian, has the most evidence: it eased overall symptoms in a 2025 review of 28 diet trials. Brain-gut therapies such as CBT and peppermint oil capsules have weaker support. Talk to your doctor about which fits you.

What are the worst foods for IBS?

There’s no single list that fits everyone. Many people react to FODMAPs, a group of carbs that ferment in the gut. In one study, people with IBS most often blamed fried foods, dairy and beans. A dietitian can help you find your own triggers.

Can IBS cause other health problems?

IBS doesn’t cause visible damage to the gut; that’s part of how doctors define it. However, it often comes with other problems. In a 2025 review of 96 studies, anxiety and depression were each linked to higher odds of IBS.

The bottom line

The short answer: IBS symptoms are belly pain tied to bowel movements, bloating, and diarrhea, constipation or both. A low FODMAP diet has the strongest evidence, while brain-gut therapies, peppermint oil capsules, fiber, exercise and probiotics have weak support.

Sources & References

  1. Cuffe, M. S., Staudacher, H. M., Aziz, I., Adame, E. C., Krieger-Grubel, C., Madrid, A. M., Ohlsson, B., Black, C. J., & Ford, A. C. (2025). Efficacy of dietary interventions in irritable bowel syndrome: A systematic review and network meta-analysis. The Lancet Gastroenterology & Hepatology, 10(6), 520-536. https://doi.org/10.1016/S2468-1253%2825%2900054-8
    Evidence: Strong. Network meta-analysis of 28 randomized trials (n=2,338 adults with IBS); low FODMAP studied in 24 trials for global symptoms; direct low FODMAP vs habitual diet comparisons rated moderate confidence, others low or very low. Funding: none.
  2. Thakur, E. R., Khasawneh, M., Moayyedi, P., Black, C. J., & Ford, A. C. (2025). Efficacy of behavioural therapies for irritable bowel syndrome: A systematic review and network meta-analysis. The Lancet Gastroenterology & Hepatology, 10(12), 1075-1088. https://doi.org/10.1016/S2468-1253%2825%2900238-9
    Evidence: Low. Network meta-analysis of 67 randomized trials (n=7,441), mostly vs a waiting list; no trial at low risk of bias, evidence of publication bias, and the authors rated all comparisons low or very low confidence, so we grade it Low. Funding: none.
  3. Black, C. J., Thakur, E. R., Houghton, L. A., Quigley, E. M. M., Moayyedi, P., & Ford, A. C. (2020). Efficacy of psychological therapies for irritable bowel syndrome: Systematic review and network meta-analysis. Gut, 69(8), 1441-1451. https://doi.org/10.1136/gutjnl-2020-321191
    Evidence: Low. Network meta-analysis of 41 randomized trials (n=4,072); all trials at high risk of bias and funnel plot asymmetry, so the authors say effects are likely overestimated. Funding: none.
  4. Ingrosso, M. R., Ianiro, G., Nee, J., Lembo, A. J., Moayyedi, P., Black, C. J., & Ford, A. C. (2022). Systematic review and meta-analysis: Efficacy of peppermint oil in irritable bowel syndrome. Alimentary Pharmacology & Therapeutics, 56(6), 932-941. https://doi.org/10.1111/apt.17179
    Evidence: Low. Meta-analysis of 10 randomized trials (n=1,030) of peppermint oil capsules vs placebo; authors rated the quality of evidence very low, so we grade it Low; adverse events more common than with placebo. Funding: unknown.
  5. Zeraattalab-Motlagh, S., Ranjbar, M., Mohammadi, H., & Adibi, P. (2025). Nutritional interventions in adult patients with irritable bowel syndrome: An umbrella review of systematic reviews and meta-analyses of randomized clinical trials. Nutrition Reviews, 83(3), e1343-e1354. https://doi.org/10.1093/nutrit/nuae107
    Evidence: Low. For soluble fiber: umbrella review of 58 meta-analyses (175 trials); effects mainly small, with low to very low certainty. Funding: unknown.
  6. Nunan, D., Cai, T., Gardener, A. D., Ordóñez-Mena, J. M., Roberts, N. W., Thomas, E. T., & Mahtani, K. R. (2022). Physical activity for treatment of irritable bowel syndrome. Cochrane Database of Systematic Reviews, (6), CD011497. https://doi.org/10.1002/14651858.CD011497.pub2
    Evidence: Low. Cochrane review of 11 randomized trials (n=622); no trial at low risk of bias; very low certainty for all outcomes. Funding: unknown.
  7. Goodoory, V. C., Khasawneh, M., Black, C. J., Quigley, E. M. M., Moayyedi, P., & Ford, A. C. (2023). Efficacy of probiotics in irritable bowel syndrome: Systematic review and meta-analysis. Gastroenterology, 165(5), 1206-1218. https://doi.org/10.1053/j.gastro.2023.07.018
    Evidence: Low. Meta-analysis of 82 randomized trials (n=10,332); only 24 at low risk of bias; moderate certainty for one strain group, low or very low for the rest. Funding: none.
  8. Sperber, A. D., Bangdiwala, S. I., Drossman, D. A., Ghoshal, U. C., Simren, M., Tack, J., et al. (2021). Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation Global Study. Gastroenterology, 160(1), 99-114.e3. https://doi.org/10.1053/j.gastro.2020.04.014
    Evidence: Reference source. Prevalence figures from a cross-sectional survey of 73,076 adults in 33 countries using Rome IV questions; not a treatment study. Funding: grants included Allergan, Shire and Takeda (industry) and Crohn’s and Colitis Canada.
  9. Lacy, B. E., Pimentel, M., Brenner, D. M., Chey, W. D., Keefer, L. A., Long, M. D., & Moshiree, B. (2021). ACG clinical guideline: Management of irritable bowel syndrome. The American Journal of Gastroenterology, 116(1), 17-44. https://doi.org/10.14309/ajg.0000000000001036
    Evidence: Reference source. How doctors diagnose IBS and which tests they consider; treatment grades on this page come from the trial reviews above.
  10. Oka, P., Parr, H., Barberio, B., Black, C. J., Savarino, E. V., & Ford, A. C. (2020). Global prevalence of irritable bowel syndrome according to Rome III or IV criteria: A systematic review and meta-analysis. The Lancet Gastroenterology & Hepatology, 5(10), 908-917. https://doi.org/10.1016/S2468-1253(20)30217-X
    Evidence: Moderate. Meta-analysis of 53 observational prevalence studies (n=395,385) for Rome III and 6 for Rome IV (n=82,476); prevalence varied with criteria and survey method. Funding: none.
  11. Arif, T. B., Ali, S. H., Bhojwani, K. D., Sadiq, M., Siddiqui, A. A., Ur-Rahman, A., Khan, M. Z., Hasan, F., & Shahzil, M. (2025). Global prevalence and risk factors of irritable bowel syndrome from 2006 to 2024 using the Rome III and IV criteria: A meta-analysis. European Journal of Gastroenterology & Hepatology, 37(12), 1314-1325. https://doi.org/10.1097/MEG.0000000000002994
    Evidence: Moderate. Meta-analysis of 96 observational studies in 52 countries; stress OR 2.47, anxiety OR 2.93, depression OR 2.24; cross-sectional data show links, not cause. Funding: unknown.
  12. Klem, F., Wadhwa, A., Prokop, L. J., Sundt, W. J., Farrugia, G., Camilleri, M., Singh, S., & Grover, M. (2017). Prevalence, risk factors, and outcomes of irritable bowel syndrome after infectious enteritis: A systematic review and meta-analysis. Gastroenterology, 152(5), 1042-1054.e1. https://doi.org/10.1053/j.gastro.2016.12.039
    Evidence: Moderate. Meta-analysis of 45 observational studies (21,421 people with enteritis); IBS in 10.1% at 12 months, risk 4.2 times higher than without enteritis. DHB note: older than our usual 2018 cutoff, but it is still the largest pooled analysis of IBS after gut infection. Funding: US National Institutes of Health.
  13. Böhn, L., Störsrud, S., Törnblom, H., Bengtsson, U., & Simrén, M. (2013). Self-reported food-related gastrointestinal symptoms in IBS are common and associated with more severe symptoms and reduced quality of life. The American Journal of Gastroenterology, 108(5), 634-641. https://doi.org/10.1038/ajg.2013.105
    Evidence: Low. Single cross-sectional questionnaire study, n=197 adults with IBS; self-reported foods, not tested triggers. DHB note: older than our usual 2018 cutoff, but it is still the main study listing which foods people with IBS blame. Funding: unknown.
  14. Irvine, A. J., Chey, W. D., & Ford, A. C. (2017). Screening for celiac disease in irritable bowel syndrome: An updated systematic review and meta-analysis. The American Journal of Gastroenterology, 112(1), 65-76. https://doi.org/10.1038/ajg.2016.466
    Evidence: Moderate. Meta-analysis of 36 observational studies (15,256 people, 9,275 with IBS symptoms); biopsy-proven celiac disease OR 4.48. DHB note: older than our usual 2018 cutoff, but it is the latest pooled analysis behind celiac testing in IBS. Funding: unknown.
  15. Lacy, B. E., Mearin, F., Chang, L., Chey, W. D., Lembo, A. J., Simren, M., & Spiller, R. (2016). Bowel disorders. Gastroenterology, 150(6), 1393-1407.e5. https://doi.org/10.1053/j.gastro.2016.02.031
    Evidence: Reference source. Rome IV expert consensus used here for the definition and the stool-based IBS types; not a treatment study.
  16. NHS. (2025). Symptoms of irritable bowel syndrome (IBS). https://www.nhs.uk/conditions/irritable-bowel-syndrome-ibs/symptoms/
    Evidence: Reference source. When to see a doctor and which warning signs need an urgent appointment (care guidance, not a study) (last reviewed March 17, 2025).

How We Reviewed This Article

We rank evidence before we write. Systematic reviews, meta-analyses, and randomized controlled trials carry the most weight. Smaller trials and observational studies get cited with appropriate caveats. Consumer-perception surveys and industry-funded work get flagged as such. Every source in the References section above is tagged with its evidence strength, so you can see the grade for yourself.

Medical Disclaimer

This article is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before making changes to your diet, exercise routine, or supplement regimen. Daily Healthy Body does not provide medical diagnoses or treatment recommendations.

Free weekly email

We read the studies. You get the Sunday summary.

The week’s new research on natural remedies and anti-inflammatory foods from Daily Healthy Body, graded and explained in one short email. No hype. Unsubscribe anytime.

One email a week. We never share your address. Privacy Policy

33 Shares:
You May Also Like